[ESPR] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
10-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -6.15%
YoY- -87.21%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -12,395 -11,466 -9,457 -9,806 -9,238 -7,874 -9,689 17.89%
Tax 337 227 135 164 18 16 47 273.18%
NP -12,395 -11,466 -9,457 -9,806 -9,238 -7,874 -9,689 17.89%
Tax Rate - - - - - - - -
Total Cost 12,395 11,466 9,457 9,806 9,238 7,874 9,689 17.89%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS -0.55 -0.56 -0.49 -0.64 -0.60 -0.51 -0.63 -8.67%
EPS Diluted -0.55 -0.56 -0.49 -0.64 -0.60 -0.51 -0.63 -8.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.